DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 173 filers reported holding DIPLOMAT PHARMACY INC in Q4 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,150,000 | -21.5% | 287,620 | -3.9% | 0.00% | – |
| Q3 2019 | $1,465,000 | -20.0% | 299,143 | -0.6% | 0.00% | – |
| Q2 2019 | $1,832,000 | -4.5% | 300,968 | -8.8% | 0.00% | -100.0% |
| Q1 2019 | $1,918,000 | +35.6% | 330,133 | +214.3% | 0.00% | – |
| Q4 2018 | $1,414,000 | -29.4% | 105,034 | +1.9% | 0.00% | -100.0% |
| Q3 2018 | $2,002,000 | -41.8% | 103,116 | -23.4% | 0.00% | 0.0% |
| Q2 2018 | $3,441,000 | -6.2% | 134,590 | -26.1% | 0.00% | 0.0% |
| Q1 2018 | $3,669,000 | -51.4% | 182,099 | -51.6% | 0.00% | -50.0% |
| Q4 2017 | $7,550,000 | +357.3% | 376,166 | +371.9% | 0.00% | – |
| Q3 2017 | $1,651,000 | -64.8% | 79,705 | -74.9% | 0.00% | -100.0% |
| Q2 2017 | $4,693,000 | -3.6% | 317,115 | +3.9% | 0.00% | 0.0% |
| Q1 2017 | $4,866,000 | -65.5% | 305,184 | -72.7% | 0.00% | -50.0% |
| Q4 2016 | $14,096,000 | +417.3% | 1,118,622 | +1049.7% | 0.00% | +100.0% |
| Q3 2016 | $2,725,000 | +53.7% | 97,299 | +92.1% | 0.00% | 0.0% |
| Q2 2016 | $1,773,000 | +6.6% | 50,663 | -16.5% | 0.00% | 0.0% |
| Q1 2016 | $1,664,000 | -48.3% | 60,702 | -35.4% | 0.00% | 0.0% |
| Q4 2015 | $3,217,000 | -54.8% | 94,026 | -62.1% | 0.00% | -66.7% |
| Q3 2015 | $7,125,000 | -43.1% | 247,969 | -11.3% | 0.00% | -25.0% |
| Q2 2015 | $12,511,000 | +181.2% | 279,581 | +117.3% | 0.00% | +100.0% |
| Q1 2015 | $4,449,000 | +216.4% | 128,654 | +150.3% | 0.00% | +100.0% |
| Q4 2014 | $1,406,000 | – | 51,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|